OXFORD NANOPORE TECHNOLOGIES PL - stock earnings
ONT.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -7.0 billion GBp | 8.6 billion GBp |
| 2023Q1 | -3.5 billion GBp | 4.3 billion GBp |
| 2022Q4 | -6.1 billion GBp | 7.6 billion GBp |
| 2022Q3 | -3.0 billion GBp | 3.8 billion GBp |
| 2022Q2 | -15.1 million GBP | 61.2 million GBP |
| 2022Q1 | -15.1 million GBP | 61.2 million GBP |
| 2021Q2 | -4.5 billion GBp | 5.9 billion GBp |
| 2020Q4 | -2.6 billion GBp | 6.6 billion GBp |
| 2020Q2 | -3.5 billion GBp | 4.8 billion GBp |
ONT.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -9.1 billion GBp | 19.9 billion GBp |
| 2021 | -16.8 billion GBp | 13.4 billion GBp |
| 2020 | -6.1 billion GBp | 11.4 billion GBp |
| 2019 | -7.2 billion GBp | 5.2 billion GBp |
| 2018 | -5.3 billion GBp | 3.3 billion GBp |
ONT.L
Price: £0.98
52 week price:
Earnings Per Share: -0.15 GBp
P/E Ratio: -10.39
Exchange: LSE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 958.3 million